Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
New England Journal of Medicine · 05.12.2024 · 391 (22) · 2075-2086
DOI: 10.1056/nejmoa2407362 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, erschienen am 05.12.2024. Verfasst von Min Soo Cho und 24 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Cardiology (M.S.C., D.-Y.K., J.-M.A., S.-J.P., D.-W.P., G.-B.N.) and the Division of Biostatics (S.-C.Y.), Asan Medical Center…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Coronary Artery Disease, Factor Xa Inhibitors, Hemorrhage. Die Arbeit wurde bisher 123-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Cardiovascular Research Foundation, Daiichi-Sankyo, Daewoong Pharmaceutical Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Cardiology (M.S.C., D.-Y.K., J.-M.A., S.-J.P., D.-W.P., G.-B.N.) and the Division of Biostatics (S.-C.Y.), Asan Medical Center, University of Ulsan College of Medicine, the Department of Cardiolog…
ORCID-Profile: Ki-Hun Kim, Duk-Woo Park
Förderung
- Cardiovascular Research Foundation
- Daiichi-Sankyo
- Daewoong Pharmaceutical Company
Zitieren
APA
Cho, M. S., Kang, D. Y., Ahn, J. M., Yun, S. C., Oh, Y. S., Lee, C. H., Choi, E. K., Lee, J. H., Kwon, C. H., Park, G. M., Choi, H. O., Park, K. H., Park, K. M., Hwang, J., Yoo, K. D., Cho, Y. R., Kim, J. H., Hwang, K. W., Jin, E. S., …, & EPIC-CAD Investigators (2024). Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease. New England Journal of Medicine, 391(22), 2075-2086. https://doi.org/10.1056/nejmoa2407362
Vancouver
Cho MS, Kang DY, Ahn JM, Yun SC, Oh YS, Lee CH, et al. Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease. New England Journal of Medicine. 2024;391(22):2075-2086. doi:10.1056/nejmoa2407362
BibTeX
@article{Cho2024,
author = {Cho, Min Soo and Kang, Do-Yoon and Ahn, Jung-Min and Yun, Sung-Cheol and Oh, Yong-Seog and Lee, Chang Hoon and Choi, Eue-Keun and Lee, Ji Hyun and Kwon, Chang Hee and Park, Gyung-Min and Choi, Hyung Oh and Park, Kyoung-Ha and Park, Kyoung-Min and Hwang, Jongmin and Yoo, Ki-Dong and Cho, Young-Rak and Kim, Ji Hyun and Hwang, Ki Won and Jin, Eun-Sun and Kwon, Osung and Kim, Ki-Hun and Park, Seung-Jung and Park, Duk-Woo and Nam, Gi-Byoung and EPIC-CAD Investigators, EPIC-CAD Investigators},
title = {Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {22},
pages = {2075--2086},
doi = {10.1056/nejmoa2407362}
}
EUVIMED